UnclearFiled 7 May 2026
Endlyz Therapeutics, Inc. raised $17.3M
Endlyz Therapeutics, Inc., a company based in Boston, MA, raised $17.3M in a new equity round, according to a filing dated 7 May 2026.
The announcement check found a page that may be about this round, and could not tell for sure. linkedin.com ↗
- Filed
- 7 May 2026
- Round
- Equity round
- Amount sold
- $17.3M
- Offering size
- $19.7M
- Investors so far
- 7
- Based in
- Boston, MA
- Website
- endlyz.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 67% of the 845 tracked raises with an amount filed in 2026.
Endlyz Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 7 May 2026 | New filing | $17.3M | This raise |
| 29 Jul 2021 | New filing | $3.25M | Another raise |
More with Dementia Discovery on the board
- Dualitas Therapeutics, Inc.$32.6M
- Therini Bio, Inc.$74.9M
- 20/20 GeneSystems, Inc.$70K
- TRex Holdings Inc.$42.3M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.